Evidence map›Paper›PMID 37511392›Full record

ArticleInternational journal of molecular sciences2023

Exosome from IFN-γ-Primed Induced Pluripotent Stem Cell-Derived Mesenchymal Stem Cells Improved Skin Inflammation and Barrier Function.

Jin Yoon, Seul Ki Lee, Arum Park, Jiho Lee, Inuk Jung, Kun Baek Song, Eom Ji Choi, Soo Kim, Jinho Yu

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
6.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Exosomes and Exosome-Mimetics for Atopic Dermatitis Therapy.Tissue engineering and regenerative medicine · 2025
    Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Exosome-Based Therapeutics in Dermatology.Biomaterials research · 2025
    Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Jin YoonAsan Institute for Life Sciences, Asan Medical Center, Seoul 05505, Republic of Korea.ORCID 0000-0003-4355-6888
Seul Ki LeeBrexogen Research Center, Brexogen Inc., Seoul 05855, Republic of Korea.
Arum ParkAsan Institute for Life Sciences, Asan Medical Center, Seoul 05505, Republic of Korea.ORCID 0000-0001-7415-8220
Jiho LeeAsan Institute for Life Sciences, Asan Medical Center, Seoul 05505, Republic of Korea.
Inuk JungSchool of Computer Science and Engineering, Kyungpook National University, Daegu 41566, Republic of Korea.ORCID 0000-0003-0675-4244
Kun Baek SongDepartment of Pediatrics, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Republic of Korea.
Eom Ji ChoiDepartment of Pediatrics, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Republic of Korea.
Soo KimBrexogen Research Center, Brexogen Inc., Seoul 05855, Republic of Korea.ORCID 0000-0002-1818-0551
Jinho YuDepartment of Pediatrics, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Republic of Korea.
Asan Medical Center · KRUlsan College · KRKyungpook National University · KR

Funding

Korea Health Industry Development Institute HI18C2439
6 · The paper itself

Abstract

The pathogenesis of atopic dermatitis (AD) is multifactorial, including immune dysregulation and epidermal barrier defects, and a novel therapeutic modality that can simultaneously target multiple pathways is needed. We investigated the therapeutic effects of exosomes (IFN-γ-iExo) secreted from IFN-γ-primed induced pluripotent stem cell-derived mesenchymal stem cells (iMSC) in mice with

Indexed as

Dermatitis, AtopicExosomesInduced Pluripotent Stem CellsMesenchymal Stem CellsAnimalsCytokinesHumansInflammationInterferon-gammaMiceRNA, MessengerSkinWaterCytokinesInterferon-gammaRNA, MessengerWateratopic dermatitisexosomeinterferon-gammamesenchymal stem cell

Identifiers

PMID37511392
PMCPMC10380988
OpenAlexW4384822305

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.